Cardiac Hypertrophy Associated with Insulin Therapy in Extremely Preterm Infants

CONCLUSIONS: Our case series supports the association between the development of CH and insulin therapy in extremely preterm infants and suggests further caution and the need for echocardiographic monitoring when treating these fragile patients with insulin.PMID:37204612 | DOI:10.1007/s40272-023-00571-0
Source: Paediatric Drugs - Category: Pediatrics Authors: Source Type: research